Skip to content

Clinical study of cerebellar iTBS combined with lower limb rehabilitation robot training in the treatment of walking dysfunction after stroke

Clinical study of cerebellar iTBS combined with lower limb rehabilitation robot training in the treatment of walking dysfunction after stroke

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074994
Enrollment
Unknown
Registered
2023-08-22
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

experimental group :active CRB-iTBS+RAGT
control group:sham CRB-iTBS+RAGT

Sponsors

China Rehabilitation Research Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1: First onset or past onset without significant sequelae (pre-stroke Modified Rankin Scale score (mRS) =1) 2: Meet the diagnostic criteria for ischemic stroke or hemorrhagic stroke. The duration of the disease is greater than 2 weeks and less than 6 months 3: Aged between 18 and 75 years (including 18 and 75 years) 4: FAC < 4 due to unilateral hemispheric stroke 5: Who understands the trial and signs the informed consent

Exclusion criteria

Exclusion criteria: 1: Neurological impairment, restriction of lower limb activity, mutilation, joint swelling, contracture, severe pain or other lower limb disorders caused by stroke, brain tumor, brain trauma, fracture, and other diseases caused by bilateral hemispheres or supratentorial lesions 2: The MAS scores of hip, knee, ankle, and toe muscle tension of the affected lower extremity are =3 3: Patients with pacemakers, cochlear implants, or other metallic foreign bodies and any electronic devices implanted in the body are contraindicated for TMS treatment 4: History of epilepsy 5: Patients with severe heart, lung, liver, kidney, and other systemic diseases that conventional drugs could not control were found through laboratory tests and examinations 6: Patients with severe aphasia (NIHSS speech item =2 points), dyslexia (NIHSS phonology item =2 points), cognitive impairment (MMSE score =20 points), deafness, etc., can not cooperate with treatment and evaluation 7: Patients with severe depression, anxiety, or a diagnosis of another mental illness. 8: A history of alcohol or drug abuse. 9: Participate in other clinical research trials.

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer Motor Assessment Scale-Lower Extremity ;

Secondary

MeasureTime frame
Berg Balance Scale ;Functional Ambulation Category ;Stroke Impact Scale ;Modified Barthel Index;

Countries

China

Contacts

Public ContactHaitao Lu

China Rehabilitation Research Center

13051760807@163.com+86 130 5176 0807

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026